Citigroup’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$677K Buy
71,164
+12,895
+22% +$100K ﹤0.01% 3367
2025
Q4
$454K Buy
58,269
+29,922
+106% +$216K ﹤0.01% 3622
2025
Q3
$215K Sell
28,347
-118,178
-81% -$984K ﹤0.01% 3960
2025
Q2
$1.31M Sell
146,525
-205,658
-58% -$1.92M ﹤0.01% 2995
2025
Q1
$2.64M Buy
352,183
+75,481
+27% +$609K ﹤0.01% 2449
2024
Q4
$2.08M Buy
276,702
+123,779
+81% +$940K ﹤0.01% 2783
2024
Q3
$1.16M Buy
152,923
+35,978
+31% +$273K ﹤0.01% 3140
2024
Q2
$723K Sell
116,945
-2,157,830
-95% -$11.9M ﹤0.01% 3134
2024
Q1
$11.6M Buy
2,274,775
+1,080,811
+91% +$6.08M 0.01% 1171
2023
Q4
$7.15M Buy
1,193,964
+822,092
+221% +$4.76M 0.01% 1382
2023
Q3
$2.63M Buy
371,872
+19,329
+5% +$139K ﹤0.01% 1813
2023
Q2
$2.48M Sell
352,543
-306,924
-47% -$2.46M ﹤0.01% 2011
2023
Q1
$5.5M Buy
659,467
+318,249
+93% +$3.06M 0.01% 1458
2022
Q4
$3.92M Sell
341,218
-133,361
-28% -$1.66M 0.01% 1598
2022
Q3
$5.98M Buy
474,579
+68,691
+17% +$884K 0.01% 1452
2022
Q2
$4.29M Buy
405,888
+338,824
+505% +$3.5M 0.01% 1619
2022
Q1
$1.09M Sell
67,064
-321,814
-83% -$5.16M ﹤0.01% 2885
2021
Q4
$5.39M Buy
388,878
+226,689
+140% +$3M ﹤0.01% 1772
2021
Q3
$2.33M Sell
162,189
-139,625
-46% -$2.2M ﹤0.01% 2414
2021
Q2
$4.77M Sell
301,814
-60,351
-17% -$820K ﹤0.01% 1930
2021
Q1
$3.68M Buy
362,165
+287,904
+388% +$2.97M ﹤0.01% 2031
2020
Q4
$554K Buy
74,261
+4,069
+6% +$21K ﹤0.01% 4114
2020
Q3
$242K Sell
70,192
-241,510
-77% -$1.04M ﹤0.01% 4477
2020
Q2
$1.49M Buy
311,702
+167,233
+116% +$668K ﹤0.01% 3137
2020
Q1
$288K Sell
144,469
-55,046
-28% -$152K ﹤0.01% 4394
2019
Q4
$688K Sell
199,515
-165,838
-45% -$417K ﹤0.01% 4129
2019
Q3
$1.05M Sell
365,353
-14,295
-4% -$44.5K ﹤0.01% 3600
2019
Q2
$1.44M Buy
379,648
+352,727
+1,310% +$2.12M ﹤0.01% 3209
2019
Q1
$219K Sell
26,921
-213,395
-89% -$1.83M ﹤0.01% 5005
2018
Q4
$1.94M Buy
240,316
+115,418
+92% +$898K ﹤0.01% 2698
2018
Q3
$953K Buy
124,898
+39,265
+46% +$264K ﹤0.01% 3557
2018
Q2
$491K Sell
85,633
-53,069
-38% -$292K ﹤0.01% 4132
2018
Q1
$662K Sell
138,702
-16,879
-11% -$86.7K ﹤0.01% 3696
2017
Q4
$764K Buy
155,581
+127,326
+451% +$617K ﹤0.01% 3620
2017
Q3
$148K Sell
28,255
-43,226
-60% -$221K ﹤0.01% 5233
2017
Q2
$398K Buy
71,481
+68,141
+2,040% +$415K ﹤0.01% 4187
2017
Q1
$28K Sell
3,340
-23,851
-88% -$166K ﹤0.01% 6071
2016
Q4
$172K Buy
27,191
+25,050
+1,170% +$130K ﹤0.01% 5402
2016
Q3
$10K Sell
2,141
-19,297
-90% -$77.1K ﹤0.01% 6523
2016
Q2
$61K Sell
21,438
-34,026
-61% -$106K ﹤0.01% 5435
2016
Q1
$157K Buy
55,464
+30,629
+123% +$136K ﹤0.01% 5308
2015
Q4
$257K Sell
24,835
-36,872
-60% -$367K ﹤0.01% 4506
2015
Q3
$703K Buy
61,707
+33,339
+118% +$445K ﹤0.01% 3419
2015
Q2
$423K Sell
28,368
-3,306
-10% -$37.6K ﹤0.01% 3851
2015
Q1
$286K Sell
31,674
-235
-0.7% -$2.43K ﹤0.01% 4205
2014
Q4
$389K Buy
31,909
+24,910
+356% +$275K ﹤0.01% 4112
2014
Q3
$68K Sell
6,999
-1,975
-22% -$24.2K ﹤0.01% 5063
2014
Q2
$115K Buy
8,974
+371
+4% +$3.61K ﹤0.01% 4573
2014
Q1
$91K Buy
8,603
+2,035
+31% +$21.7K ﹤0.01% 5070
2013
Q4
$50K Buy
6,568
+4,527
+222% +$28.7K ﹤0.01% 5726
2013
Q3
$15K Sell
2,041
-149
-7% -$756 ﹤0.01% 6039
2013
Q2
$3K Buy
+2,190
New +$3.78K ﹤0.01% 6440

Other funds holding BCRX